There were 1,681 press releases posted in the last 24 hours and 359,336 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image